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Summary
Various treatment procedures for precancerous lesions in the oral cavity have been reported: excision surgery, electro-
coagulation, cryosurgery, laser surgery, the local use of corticoids and administration of vitamin A. The main objective in 
the treatment of precancerous lesions of the oral cavity is to remove potentially neoplastic cells due to the possibility of 
 recurrence and/or malignant transformation from those cells. Lasers are widely accepted and used in medicine and den-
tistry due to their benefi cial eﬀ ects: coagulation properties (less perioperative and postoperative bleeding), and less postop-
erative pain and oedema. Furthermore, laser therapy results in good and fast healing process, a low level of patient’s dis-
comfort during and after surgical intervention, as well as rapid disappearance of postsurgical symptoms. Pubmed was 
searched in order to fi nd out published papers in the last 20 years (1996-2016) regarding the usage of various lasers in the 
treatment of precancerous lesions of the oral cavity. Using the terms “laser” and “oral precancerous lesion” 27 articles were 
found in the searched period. Since the oral leukoplakia is the most precancerous condition in the oral cavity, next search 
was based on the terms “laser” and “oral leukoplakia” when 122 articles were found. Review articles and clinical trials writ-
ten on the English language were included in presented systematic review.
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USPOREDBA RAZLIČITIH LASERA U LIJEČENJU PREKANCEROZA U ORALNOJ ŠUPLJINI
Sažetak
U liječenju prekanceroza u oralnoj šupljini, koriste se standardne kirurške tehnike, laserska kirurgija, kriokirurgija, 
elektrokoagulacija, lokalna uporaba kortikosteroida i vitamina A. Tim postupcima uklanja se prekancerozno tkivno, sprije-
čava maligna transformacija i metastaziranje. Laser je prihvaćen u medicini zbog manjeg operacijskog i poslijeoperacijskog 
krvarenja, boli, edema i bržeg cijeljenja rane. Pretražena je baze podataka PubMed - NCBI o uporabi lasera za liječenje oral-
nih prekanceroza u razdoblju od 20 godina (1996. do 2016.) Pod ključnim riječima “laser! i “oral precancerous lesion”, nađe-
no je 27 članaka. Leukoplakija je najčešća prekanceroza u ustima, pa je pod “laser” i “oral leucoplakia” nađeno 122 članka. 
Slijedi osvrt na te radove.
KLJUČNE RIJEČI: prekanceroze, leukoplakija, eritroplakija, ustni lichen planus, laser, kirurgija
INTRODUCTION
Lasers are widely accepted and used in med-
icine and dentistry due to their benefi cial eﬀ ects 
such as: coagulation properties (less perioperative 
and postoperative bleeding), and less postopera-
tive pain and oedema. Furthermore, laser therapy 
results in good and fast healing process, a low 
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level of patient’s discomfort during and after sur-
gical intervention, as well as rapid disappearance 
of postsurgical symptoms (1). The main objective 
in the treatment of precancerous lesions of the oral 
cavity is to remove potentially neoplastic cells due 
to the possibility of recurrence and/or malignant 
transformation from those cells (2).
Laser surgery has many advantages for both 
the surgeon and patient. It can control hemorrhag-
ing while the surgeon has excellent visibility dur-
ing operation and enables shortening of the opera-
tive time. Patients do not require a special method 
to stop bleeding after surgery. In addition, there is 
minimal damage to adjacent tissue, thus reducing 
acute infl ammatory reactions and postoperative 
pain, swelling, oedema or infections. Sealing of 
blood and lymphatic vessels diminishes the risk of 
disseminating neoplastic cells int he treatment of 
malignant lesions, and sealing oft he nerve endings 
reduces postoperative pain (3). Laser surgery re-
sults in excellent healing process because of the 
limited scarring and contraction, and there is satis-
factory mobility of the soft tissues. However, laser 
surgery has some disadvantages. The major is that 
the biopsy should be obtained using other meth-
ods, preoperatively or at the time of laser treatment. 
Epithelial regeneration after laser surgery is de-
layed, and wound healing process takes longer to 
re-epithelialize when compared to conventional 
surgery. The last disadvantage is safety precau-
tions, namely, the use of eye-glasses is required to 
protect both the patient and the medical staﬀ  (4).
However, some authors speculate that tem-
perature-induced injuries due to laser light appli-
cation and questionable possibility of post-opera-
tive histopathological evaluation of the sampled 
tissue might be a drawback in laser use. Azavedo 
et al. (5) reported that diﬀ erent lasers using diﬀ er-
ent parameters (Er:YAG at 2W with and without 
air/water spray and at 4W with and without air/
water spray; CO2 at 3.5W and 7W in pulsed mode 
and at 7W in continuous mode; the diode laser at 
3.5W and boost 3.5W in pulsed mode; Nd:YAG at 
6W, 40Hz) can be used in soft oral tissues biopsies 
as they are capable of providing a correct histo-
pathological analysis. This study was performed 
on pork mucosa.
  The main asset of the CO2 laser comparing 
to Er:YAG laser is an eﬀ ective coagulation while 
thermal injury to the tissues is its limitation, espe-
cially with multiple passage of the beam and too 
high power applied. Er:YAG laser application 
does not exclude histopathological examination of 
the removed lesion tissue which is its advantage 
over CO2 laser. Still, insuﬃ  cient coagulation is a 
limitation of its use in the case of richly vascular-
ized lesions (6). Kharadi et al. (7) applied 940 nm 
diode laser in ten patients with oral leukoplakia 
and reported perfect healing process and mild 
pain intensity.
Some results indicate that for CO2 laser treat-
ment of premalignant lesions of the oral mucosa, 
the best results can be achieved with the defo-
cused technique. Other methods with lesser pen-
etration of thermal eﬀ ects (e.g. sp, scanner) do not 
reach the deeper-lying cells and, consequently, 
render higher rates of recurrences. Continuous 
smoking after surgical treatment and widespread 
multiple-focus lesions are the prognostic indica-
tors for recurrence after laser surgery (8).
White et al. (9) retrospectively evaluated 39 
patients with oral leukoplakia and concluded that 
CO2 and Nd:YAG lasers were successful surgical 
options due to the minimal postoperative pain, 
minimally invasive therapy, and elimination of 
sutures.
METHODS AND RESULTS
Pubmed was searched in order to fi nd out 
published papers in the last 20 years (1996-2016) 
regarding the usage of various lasers in the treat-
ment of precancerous lesions of the oral cavity. 
Using the terms “laser” and “oral precancerous le-
sion” 27 articles were found in the searched peri-
od. Since the oral leukoplakia is the most precan-
cerous condition in the oral cavity, next search 
was based on the terms “laser” and “oral leuko-
plakia” when 122 articles were found. Review ar-
ticles and clinical trials writt en on the English lan-
guage were included in presented systematic re-
view.
DISCUSSION
Various treatment procedures for precancer-
ous lesions in the oral cavity have been reported: 
excision surgery (10), electrocoagulation (11), 
cryosurgery (12), laser surgery (3-10), the local use 
of corticoids and administration of vitamin A (13). 
An objective of the treatments for precancerous le-
39
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sions of the oral cavity is to completely inhibit cell 
proliferation, or the disappearance of potentially 
neoplastic cells in the lesion, because there is a 
possibility of recurrence and/or malignant trans-
formation from those cells (4). Excision surgery 
removes abnormal cells and causes postoperative 
scarring (10). Electrocoagulation produces ther-
mal damage in the underlying tissue, which causes 
postoperative pain, edema and leads to consider-
able scarring (4). Cryosurgery causes tissue necro-
sis by freezing intra- and extracellular free fl uid (4, 
12). The absorbed energy by laser surgery causes 
vaporization of the intra- and extracellular fl uid 
and destruction of the cell membranes (4-9).  The 
CO2 laser is the most used laser on the oral cavity 
during the past decade because of its aﬃ  nity for 
water and high absorption by the oral mucosa. 
The use of the CO2 laser does not reduce the risk of 
relapses of the lesion, but it is an easy-to-use tech-
nique and results in both a quick surgical proce-
dure and trouble-free postoperative period and 
may be safely used in dental practice (14).
Oral leukoplakia
Leukoplakia is defi ned as „A white plaque or 
patch of questionable risk having excluded (other) 
known diseases or disorders that carry no increased 
risk for cancer” (15). The estimated prevalence of 
oral leukoplakia worldwide is approximately two 
percent (2, 4). There are some geographical diﬀ er-
ences with regard to the gender distribution. Leu-
koplakia is much more common among smokers 
(2). An annual malignant transformation rate is of 
approximately 1% is probably a realistic fi gure for 
all clinically and/or histopathological types of oral 
leukoplakia together. Risk factors of statistical sig-
nifi cance for malignant transformation of oral leu-
koplakia are female gender, long duration of lesion, 
no-smokers, location on the tongue and fl oor of the 
mouth, size, non-homogeneous type, epithelial 
dysplasia and DNA aneuploidy (16). The most 
commonly used treatment modalities consist of 
surgical excision or CO2 laser therapy. Recurrence 
rates after any type of treatment may vary from al-
most zero to up to 30%, probably mainly depend-
ing on the length of follow-up (2).
Diode laser
Fornaini et al. (17) compared four diode laser 
wavelengths (810, 980, 1470 and 1950 nm) for the 
ablation of the bovine tongues and signifi cant 
temperature increase was recorded by 980 nm la-
ser and the lowest by 1950 nm laser. The same au-
thors concluded that the incision was bett er and 
tissue injuries were minor in the specimens ob-
tained with higher wavelength (1950 nm) and at 
lower power (2W). Other group of authors (18) 
found wavelength of 810 nm to be potentially the 
best choise int he oral soft tissue surgery. Kundoor 
et al (19) reported satisfactory clinical results after 
treatment of oral leukoplakia and oral lichen pla-
nus using diode laser.
Carbon dioxide laser
Mogedas-Vegara et al. (8) performed a sys-
tematic review of the 33 papers (published be-
tween the years 1981. and 2015.) to evaluate treat-
ment of oral leukoplakia with the carbon dioxide 
(CO2) laser. The same authors concluded that CO2 
laser is excellent in the oral leukoplakia treatment 
due to its eﬀ ectiveness and low associated mor-
bidity, however, randomized clinical trials are 
needed to compare CO2 laser with other surgical 
lasers.
Huang et al. (20) treated 22 patients with oral 
leukoplakia and 18 patients with oral lichen pla-
nus. Two patients with oral leukoplakia showed 
recurrence after the surgery, whereas there was no 
recurrence after laser. Therefore, the same authors 
concluded that CO2 laser in the treatment of oral 
mucosal lesions has the advantages in terms of re-
duced bleeding, a clear view during surgery, and 
a shorter operative time.
Tambuwala et al. (10) treated 30 patients with 
oral leukoplakia by use of CO2 laser and scalpel 
and concluded that CO2 laser showed superior re-
sults when compared to the scalpel regarding bet-
ter intra-operative and reduced scarring. There 
were no diﬀ erences between CO2 laser and scalpel 
regarding post-operative pain and swelling after 
laser excision did not show any signifi cant diﬀ er-
ence from that of scalpel.
Lopez-Jornet et al. (21) compared conven-
tional surgery with carbon dioxide (CO2) laser in 
48 patients with oral leukoplakia with regard to 
the postoperative pain and swelling and conclud-
ed that the CO2 laser causes only minimal pain 
and swelling, making it as a valuable method to 




Lim et al. (22) reported that the use of KTP 
(potassium-titanyl phosphate) lasers for the treat-
ment of oral leukoplakia may result in lower re-
currence rates than when using CO2 lasers.
Schoelch et al. (23) treated 39 patients with 
some degree of microscopic dysplasia and six 
which demonstrated high-risk proliferative verru-
cous leukoplakia by applying CO2 and Nd:YAG 
lasers. None of the complications occurred except 
that two patients developed pyogenic granulomas 
in their surgical sites. Twenty-nine patients had 
complete control of their lesions; 19 patients had 
small recurrences; 2 patients had complete recur-
rences; and 5 patients developed squamous cell 
carcinoma at the lesion site. Verrucous lesions had 
an especially high rate of recurrence (83%), with 9 
of 12 ultimately controlled with subsequent sur-
geries.
Deppe et al. (24) evalutaed the recurrence 
rate resulting from diﬀ erent methods after CO2 
evaporization. In that study 148 premalignant le-
sions were treated. Statistically signifi cant lowest 
recurrence rates were yielded by the defocused 
cw-technique followed by the cw-scanner and the 
sp-mode. The results indicated that the best re-
sults when treating premalignant lesions of the 
oral mucosa can be achieved using defocused 
technique of CO2 laser while other methods with 
lesser penetration of thermal eﬀ ects do not reach 
the deeper-lying cells and, consequently, render 
higher rates of recurrence.
Brouns et al (25) in their cohort study on 35 
patients found that the annual recurrence rate of 
oral leukoplakia treated with CO2 laser was ap-
proximately 8%, which is signifi cantly higher then 
in previous literature. Next year the same authors 
published another paper (26) on the topic of ma-
lignant transformation of oral leukoplakia in sam-
ple of 144 patients. They found that malignant 
transformation occured in 11% of patients, and 
concluded that annual malignant transformation 
rate is approximately 2.6%. they also found that 
the large size of lesion showed to be the only sta-
tistically signifi cant predictor of malignant trans-
formation of the oral leukoplakia. Similar rate of 
malignant transformation (10.4%) was observed 
in the study of Jersej et al. (27). The same authors 
observed the recurrence rate of approximately 
19.5% after CO2 laser surgery. Another group of 
authors (28) found lower recurrence rate (15%) af-
ter treating the oral leukoplakias with the same 
laser technique.
Neodymium-doped ytt rium aluminium 
garnet laser
Vivek et al. (29) treated 28 patients with his-
tologically proven leukoplakia by use of Nd:YAG 
laser and patients had only mild to moderate pain, 
swelling and restricted mouth opening, which 
peaked between 72 h and 1 week. Cure rate was 
92.86% in a 6-month period.  Longer period of 
postsurgical follow-up reported Tewari et al. (30) 
and Das et al. (31) with similar clinical results and 
successful rate.  Montebugnoli et al. (32) in their 
prospective study observed that clinical healing of 
leukoplakia treated by Nd:YAG laser surgery may 
be accompanied by altered cell turnover in 20% oft 
he cases. 
Erbium-doped ytt rium aluminium garnet laser
There are only two reports on the use of 
Er:YAG laser in the treatment of oral leukoplakia 
(33, 34).  Meister et al. (33) used Er:YAG laser to 
treat leukoplakia of the buccal mucosa which was 
completely ablated and complete remission was 
seen.
Earlier clinical study by Schwartz  et al. (34) 
compared the eﬃ  cacy of Er:YAG and CO2 laser in 
oral leukoplakia ablation, where authors conclud-
ed that the both treatment modalities still have 
some limitations to achieve predictable eradica-
tion of oral leukoplakia. 
Erbium, chromium: 
ytt rium-scandium-gallium-garnet
In comparison to the scalpel surgery one 
might suspect that lesions removed with lasers 
could not be utilized for histopathology analyses. 
However, Seoane et al. (35) concluded that irradi-
ation with Er,Cr:YSGG laser induces a minimal 
amount of thermal artifacts at the surgical mar-
gins of oral leukoplakias and avoids diagnostic 
interferences with real dysplastic borders.
Oral lichen planus
Oral lichen planus is generally regarded to 
represent a potentially malignant disorder. The 
reported annual malignant transformation rate is 
probably less then 0.5%. the issue of malignant 
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transformation in oral lichen planus is blurred by 
the lack of clinicopathologic correlation in the di-
agnosis. The eﬃ  cacy of continuous follow-up of 
oral lichen planus patients is questionable (2)
Misra et al. (36) treated patient with OLP le-
sions using diode laser (940 nm) and there was 
complete remission of painful OLP symptoms. De 
Magalhaes et al. (37) treated patients with OLP by 
use of CO2 laser in order to remove lesion and af-
ter one year there were no signs of recurrence. 
Therefore, the same authors concluded that CO2 
laser is useful for the tretament of oral lichen pla-
nus. Furthermore, van der Hem et al. (38) treated 
21 patients with 39 OLP lesions by use of CO2 laser 
and after 1-18 years at follow-up visit, 21 were 
painless and 6 patients had painful OLP recur-
rence. Previously all these patients were unre-
sponsive to the golden standard with corticoste-
roid treatment and therefore the same authors 
suggest CO2 lasers in the tretament of painful OLP 
lesions.
Fornaini et al. (39) used Er:YAG laser in two 
patients with OLP were as follows: energy, 80-120 
mJ; frequency, 6-15 Hz; non-contact hand piece; 
spot size diameter, 0.9 mm; pulse duration, 100 
μsec (VSP) to 300 μsec (SP) ; fl uences, 12.6-18.9 J/
cm(2); and air/water spray (ratio: 6/5). A very 
small OLP recurrence was seen in one patient after 
15 months. On the other hand, Agha-Hosseini et 
al. (40) reported that low-level laser therapy was 
superior to CO2 laser with regard to the size of 
OLP lesions and pain.
Erythroplakia
Erythroplakia is defi ned in a similar way as 
leukoplakia, being a “A fi ery red patch that cannot 
be characterized clinically or pathologically as any 
other defi nable disease.“ The clinical appereance 
is often a fl at or depressed erythematous change 
oft he oral mucosa. Erythroplakia needs to be 
treated because of its high risk of malignant trans-
formation. Most of the lesions are symptomatic. 
Surgery, either a cold knife or by laser excision is 
the recommended treatment modality- there are 
no data from the literature about the recurrence 
rate after excision of erythroplakia (2).
Yang et al. (41) treated 84 patients with inva-
sive carcinoma (n=3), dysplasia/carcinoma in situ 
(n=61), and squamous hyperplasia (n=20) by car-
bon dioxide laser excision. There was no postop-
erative malignant transformation, but invasive 
carcinoma found after initial excision (n=3) was 
treated by further radical excision. The same au-
thors (42) concluded that laser excision is eﬀ ective 
in treating oral erythroplakia that is still confi ned 
to dysplasia of any degree, with low morbidity. 
The area of oral erythroplakia is a predictive factor 
for postoperative recurrence.
Cantarelli Morosolli et al. (43) treated patient 
with erythroleukoplakia involving the lower lip 
CO2 laser with 0.8 mm focus, 5 W, power density 
of 2.5 W/cm2 in continuous mode. After 6 months, 
no recurrence was seen.
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